USA Synthetic Opioids Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Opioids is extracted from opioid (poppy) alkaloid derivatives in vivo and in vitro, and interact with central specific receptor, can relieve pain, produce happiness is extracted from opioid (poppy) alkaloid derivatives in vivo and in vitro, and interact with central specific receptor, can relieve pain, create happiness.

    Rise in the number of patients suffering from terminal illnesses such as a severe cough resulting from lung infection, cancer, HIV, along with a high surge in the prescription for post-operative pain medication are factors expected to boost the consumption of semi-synthetic opioids as pain medication.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Synthetic Opioids market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Synthetic Opioids market. Detailed analysis of key players, along with key growth strategies adopted by Synthetic Opioids industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Teva Pharmaceuticals

    • Endo International

    • Mallinckrodt Pharmaceuticals

    • Indivior

    • Impax Laboratories

    • Janssen Pharmaceuticals

    • West-Ward Pharmaceuticals

    • Mylan

    • Purdue Pharma

    • Pfizer

    By Type:

    • Methadone

    • Fentanyl

    • Meperidine

    • Hydrocodone

    • Oxymorphone

    • Oxycodone

    By End-User:

    • Pain Management

    • De-addiction

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Synthetic Opioids Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Synthetic Opioids Market Size and Growth Rate of Methadone from 2016 to 2027

      • 1.3.2 USA Synthetic Opioids Market Size and Growth Rate of Fentanyl from 2016 to 2027

      • 1.3.3 USA Synthetic Opioids Market Size and Growth Rate of Meperidine from 2016 to 2027

      • 1.3.4 USA Synthetic Opioids Market Size and Growth Rate of Hydrocodone from 2016 to 2027

      • 1.3.5 USA Synthetic Opioids Market Size and Growth Rate of Oxymorphone from 2016 to 2027

      • 1.3.6 USA Synthetic Opioids Market Size and Growth Rate of Oxycodone from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Synthetic Opioids Market Size and Growth Rate of Pain Management from 2016 to 2027

      • 1.4.2 USA Synthetic Opioids Market Size and Growth Rate of De-addiction from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Synthetic Opioids Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Synthetic Opioids by Major Types

      • 3.4.1 Market Size and Growth Rate of Methadone

      • 3.4.2 Market Size and Growth Rate of Fentanyl

      • 3.4.3 Market Size and Growth Rate of Meperidine

      • 3.4.4 Market Size and Growth Rate of Hydrocodone

      • 3.4.5 Market Size and Growth Rate of Oxymorphone

      • 3.4.6 Market Size and Growth Rate of Oxycodone

    4 Segmentation of Synthetic Opioids Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Synthetic Opioids by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Synthetic Opioids in Pain Management

      • 4.4.2 Market Size and Growth Rate of Synthetic Opioids in De-addiction

    5 Market Analysis by Regions

    • 5.1 USA Synthetic Opioids Production Analysis by Regions

    • 5.2 USA Synthetic Opioids Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Synthetic Opioids Landscape Analysis

    • 6.1 West USA Synthetic Opioids Landscape Analysis by Major Types

    • 6.2 West USA Synthetic Opioids Landscape Analysis by Major End-Users

    7 South USA Synthetic Opioids Landscape Analysis

    • 7.1 South USA Synthetic Opioids Landscape Analysis by Major Types

    • 7.2 South USA Synthetic Opioids Landscape Analysis by Major End-Users

    8 Middle West USA Synthetic Opioids Landscape Analysis

    • 8.1 Middle West USA Synthetic Opioids Landscape Analysis by Major Types

    • 8.2 Middle West USA Synthetic Opioids Landscape Analysis by Major End-Users

    9 Northeast USA Synthetic Opioids Landscape Analysis

    • 9.1 Northeast USA Synthetic Opioids Landscape Analysis by Major Types

    • 9.2 Northeast USA Synthetic Opioids Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Teva Pharmaceuticals

        • 10.1.1 Teva Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Endo International

        • 10.2.1 Endo International Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Mallinckrodt Pharmaceuticals

        • 10.3.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Indivior

        • 10.4.1 Indivior Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Impax Laboratories

        • 10.5.1 Impax Laboratories Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Janssen Pharmaceuticals

        • 10.6.1 Janssen Pharmaceuticals Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 West-Ward Pharmaceuticals

        • 10.7.1 West-Ward Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Mylan

        • 10.8.1 Mylan Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Purdue Pharma

        • 10.9.1 Purdue Pharma Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Pfizer

        • 10.10.1 Pfizer Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Methadone from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Fentanyl from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Meperidine from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Hydrocodone from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Oxymorphone from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Oxycodone from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of Pain Management from 2016 to 2027

    • Figure USA Synthetic Opioids Market Size and Growth Rate of De-addiction from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Synthetic Opioids Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Synthetic Opioids Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Synthetic Opioids

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Synthetic Opioids by Different Types from 2016 to 2027

    • Table Consumption Share of Synthetic Opioids by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Methadone

    • Figure Market Size and Growth Rate of Fentanyl

    • Figure Market Size and Growth Rate of Meperidine

    • Figure Market Size and Growth Rate of Hydrocodone

    • Figure Market Size and Growth Rate of Oxymorphone

    • Figure Market Size and Growth Rate of Oxycodone

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Synthetic Opioids by Different End-Users from 2016 to 2027

    • Table Consumption Share of Synthetic Opioids by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pain Management

    • Figure Market Size and Growth Rate of De-addiction

    • Table USA Synthetic Opioids Production by Regions

    • Table USA Synthetic Opioids Production Share by Regions

    • Figure USA Synthetic Opioids Production Share by Regions in 2016

    • Figure USA Synthetic Opioids Production Share by Regions in 2021

    • Figure USA Synthetic Opioids Production Share by Regions in 2027

    • Table USA Synthetic Opioids Consumption by Regions

    • Table USA Synthetic Opioids Consumption Share by Regions

    • Figure USA Synthetic Opioids Consumption Share by Regions in 2016

    • Figure USA Synthetic Opioids Consumption Share by Regions in 2021

    • Figure USA Synthetic Opioids Consumption Share by Regions in 2027

    • Table West USA Synthetic Opioids Consumption by Types from 2016 to 2027

    • Table West USA Synthetic Opioids Consumption Share by Types from 2016 to 2027

    • Figure West USA Synthetic Opioids Consumption Share by Types in 2016

    • Figure West USA Synthetic Opioids Consumption Share by Types in 2021

    • Figure West USA Synthetic Opioids Consumption Share by Types in 2027

    • Table West USA Synthetic Opioids Consumption by End-Users from 2016 to 2027

    • Table West USA Synthetic Opioids Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Synthetic Opioids Consumption Share by End-Users in 2016

    • Figure West USA Synthetic Opioids Consumption Share by End-Users in 2021

    • Figure West USA Synthetic Opioids Consumption Share by End-Users in 2027

    • Table South USA Synthetic Opioids Consumption by Types from 2016 to 2027

    • Table South USA Synthetic Opioids Consumption Share by Types from 2016 to 2027

    • Figure South USA Synthetic Opioids Consumption Share by Types in 2016

    • Figure South USA Synthetic Opioids Consumption Share by Types in 2021

    • Figure South USA Synthetic Opioids Consumption Share by Types in 2027

    • Table South USA Synthetic Opioids Consumption by End-Users from 2016 to 2027

    • Table South USA Synthetic Opioids Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Synthetic Opioids Consumption Share by End-Users in 2016

    • Figure South USA Synthetic Opioids Consumption Share by End-Users in 2021

    • Figure South USA Synthetic Opioids Consumption Share by End-Users in 2027

    • Table Middle West USA Synthetic Opioids Consumption by Types from 2016 to 2027

    • Table Middle West USA Synthetic Opioids Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Synthetic Opioids Consumption Share by Types in 2016

    • Figure Middle West USA Synthetic Opioids Consumption Share by Types in 2021

    • Figure Middle West USA Synthetic Opioids Consumption Share by Types in 2027

    • Table Middle West USA Synthetic Opioids Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Synthetic Opioids Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Synthetic Opioids Consumption Share by End-Users in 2016

    • Figure Middle West USA Synthetic Opioids Consumption Share by End-Users in 2021

    • Figure Middle West USA Synthetic Opioids Consumption Share by End-Users in 2027

    • Table Northeast USA Synthetic Opioids Consumption by Types from 2016 to 2027

    • Table Northeast USA Synthetic Opioids Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Synthetic Opioids Consumption Share by Types in 2016

    • Figure Northeast USA Synthetic Opioids Consumption Share by Types in 2021

    • Figure Northeast USA Synthetic Opioids Consumption Share by Types in 2027

    • Table Northeast USA Synthetic Opioids Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Synthetic Opioids Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Synthetic Opioids Consumption Share by End-Users in 2016

    • Figure Northeast USA Synthetic Opioids Consumption Share by End-Users in 2021

    • Figure Northeast USA Synthetic Opioids Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Teva Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals

    • Table Product and Service Introduction of Teva Pharmaceuticals

    • Table Company Profile and Development Status of Endo International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo International

    • Figure Sales and Growth Rate Analysis of Endo International

    • Figure Revenue and Market Share Analysis of Endo International

    • Table Product and Service Introduction of Endo International

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Indivior

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indivior

    • Figure Sales and Growth Rate Analysis of Indivior

    • Figure Revenue and Market Share Analysis of Indivior

    • Table Product and Service Introduction of Indivior

    • Table Company Profile and Development Status of Impax Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Impax Laboratories

    • Figure Sales and Growth Rate Analysis of Impax Laboratories

    • Figure Revenue and Market Share Analysis of Impax Laboratories

    • Table Product and Service Introduction of Impax Laboratories

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals

    • Table Company Profile and Development Status of West-Ward Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of West-Ward Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of West-Ward Pharmaceuticals

    • Figure Revenue and Market Share Analysis of West-Ward Pharmaceuticals

    • Table Product and Service Introduction of West-Ward Pharmaceuticals

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.